Joslin Study on the Genetics of Type 2 Diabetes

Request Access

Anthropometry (1)

Biomarkers (4)

  • ALBUMIN:CREATININE RATIO - Albumin Creatinine Ratio (mg/mg) (phv00506017.v1.p1)
  • HLA_STATUS - Human leukocyte antigen (HLA) alleles DR3 (haplotype DQA1*05:01-DQB1*02:01) and DR4 (haplotype DQA1*03-DQB1*03:02) (phv00506021.v1.p1)
  • HYPER-CERAMIDEMIA - High levels of C16:0 ceramide (Yes/No) (phv00506020.v1.p1)
  • HYPO-ADIPONECTINEMIA - Low levels of circulating adiponectin (Yes/No) (phv00506019.v1.p1)

Demographics (3)

  • AGE_AT_DIABETES_DIAGNOSIS - Age when subject was diagnosed with diabetes (phv00506014.v1.p1)
  • AGE_AT_EXAMINATION - Age when subject enrolled in the Joslin Study of Genetics of Nephropathy in Type 2 Diabetes (phv00506011.v1.p1)
  • SEX - Biological sex (phv00506007.v1.p1)

Disease Events (3)

  • DIABETES - Subject's diabetes status at enrollment into the Joslin Study of Genetics of Nephropathy in Type 2 Diabetes (phv00506012.v1.p1)
  • DURATION_OF_DIABETES - Duration (in years) of diabetes (phv00506015.v1.p1)
  • ESRD - End-stage Renal Disease status (Yes/No) (phv00506018.v1.p1)

Medications (1)

  • DIABETES_TREATMENT - Treatment provided to subject (Oral prescription, Insulin, Diet, Unknown, Not applicable) (phv00506016.v1.p1)

Other (10)